AM Policy Update: March 15, 2026
The DEA scheduling cannabis policy update on March 15, 2026, highlights key regulatory changes affecting cannabis medicine. This includes temporary placements and rescheduling of substances relevant to controlled substances regulations. Understanding…
Importer of Controlled-Biopharmaceutical (2024-20085) DEA1425 Notice
The importer controlled biopharmaceutical regulations are critical for compliance with DEA standards in 2024. This notice highlights key regulatory updates affecting importers of controlled biopharmaceutical substances. Understanding these regulations…
Schedules of Controlled Substances: Temporary Placement of N-pyrrolidino metonitazene and N-pyrrolidino protonitazene in Schedule I
Nitazene synthetic opioids such as N-pyrrolidino metonitazene and N-pyrrolidino protonitazene have been temporarily placed in Schedule I. These substances pose significant overdose risks and are emerging threats in illicit drug supplies. Clinicians…